Azacitidine and Lenalidomide for Relapsed and Refractory Patients With Acute Myeloid Leukemia

NCT01743859 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

37

Enrollment

OTHER

Sponsor class

Conditions

Acute Myeloid Leukemia

Interventions

DRUG: Azacitidine
DRUG: Lenalidomide
OTHER: Off Therapy

Sponsor

University of Colorado, Denver

Collaborators

[object Object]